<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">636581C2BDCD12DA36F0AB8CF5623E9C</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T23:04+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SpLine BM25A -details</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Contacts</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Germán R. Castro</head><p>Scientist in charge of beamline castro@esrf.fr +33 (0)4. <ref type="bibr">76.88.22.64</ref> Detectors: 13-element Si(Li) detector from e2v Scientific Instruments Technical details on the beamline: High-resolution powder diffraction (HRPD) measurements can be performed within a photon energy range between 5 and 45 keV. Hence, K and L-edge resonance experiments can be performed together with non-resonance experiments. An HRPD set-up is installed at the focal plane A2 (~45 m from the source). A heavy-duty theta-two-theta diffractometer with a distance from the center to the detector of at least 50 cm has been installed. The angular resolution for the detector movement is 0.0001 degrees. The main axis for the theta and twotheta circles is horizontal, such that diffraction measurements are realized in the vertical plane. For HRPD samples can be accommodated in capillaries of different diameter according to the available amount of sample or by the concentration of the chemical species present in the sample and the photon energy used. The in-situ thermal treatment systems do not interfere with the detector movement. The HRPD station will be upgraded with the acquisition of a new Theta-TwoTheta diffractometer with a detector stage custom-designed for SpLine. This stage incorporates 10 single point-detectors operated in parallel, and each point detector is equipped with a Ge single crystal analyzer. The diffractometer, which is manufactured by HUBER GmbH, can be used in reflection and transmission (thin films and capillary) configuration and will be delivered and commissioned by the end of 2010. 2. X-Ray absorption spectroscopy measurements can be performed within a photon energy range between 5 and 45 keV. Hence, K and/or L edge for the most relevant chemical species can be scanned. The sample environment has enough free space to install baby chambers, reactors, cryostats, ovens, etc.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Proposal summary</head><p>Our work on the structural elucidation of bioinspired metal organic frameworks for controlled drug release, using active pharmaceutical ingredients (API), and safe metals, is an ongoing project (see reports on CH3876 and CH4160) <ref type="bibr" target="#b16">[1,</ref><ref type="bibr" target="#b17">2]</ref>. Lately we have extended our interests to systems containing zeolitic imidazolate frameworks build up with psychoactive drugs, the main idea being increasing their ability to cross the BBB, and thus decreasing the amount of drug intake needed and more importantly drastically reducing the side effects. Careful structural elucidation of these systems is at the moment our main aim and recurring to X-ray diffraction is envisaged by us as one of the most important tools. Currently we are strongly relying in powder diffraction to proceed with the structural characterization, but for the success of this task we believe it is crucial to access high-resolution data collected at the ESRF. As previously we are able to obtain some microcrystals whose analysis is also of utmost importance.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 1 -Aim of the project</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Scientific background</head><p>Our project applies the underlying concepts of MOFs in biological and medicinal chemistry by synthesizing BioMOFs, "bioinspired" MOFs, using active pharmaceutical ingredients (API) and mainly non-toxic metals such as Fe, Mg, Zn, Mn and Bi, for potential use in the transport and release of APIs. The first families of MOFs considered as potential drug delivery systems were the CPO-27(Mg) (CPO for Coordination Polymer from Oslo), built up from Mg coordination polymers and the MIL (Materials of Institut Lavoisier) family <ref type="bibr">[4]</ref>. Horcajada and co-workers prepared MIL100 and MIL101 for the delivery of ibuprofen, exhibiting a high drug storage capacity and a complete drug controlled release under physiological conditions from 3 to 6 days <ref type="bibr">[4,</ref><ref type="bibr" target="#b24">5]</ref>; and the first biodegradable therapeutic MOF was BioMIL-1, prepared from iron(III) acetate and nicotinic acid <ref type="bibr" target="#b24">[5]</ref>. Therefore having API as the organic fragment is undoubtedly promising, turning BioMOFs into one of the best possible nanocarrier <ref type="bibr" target="#b25">[6,</ref><ref type="bibr" target="#b26">7,</ref><ref type="bibr" target="#b27">8]</ref>.</p><p>Our group is addressing different approaches to attain these goals: (I) having API as linkers, what would be attained by the direct coupling of the bioactive molecule to the metal; (II) having the drug carried within the pores as guest with suitable pore sizes; (III) enclosing in the same BioMOF drugs acting both as linkers and guests. The first approach avoids the need of large pore sizes, without additional side effects, since the release of the API is achieved by material degradation. We are also starting to work with zeolite-like metal-organic frameworks (ZMOFs) and zeolitic imidazolate frameworks (ZIFs). ZIFs, in particular ZIF-8, have been successfully explored for the controlled release of anti-cancer drugs, making use of its pHsensitivity release properties. <ref type="bibr">[9]</ref> More recently, we have been focused on systems containing muconic acid, adenine, pirlindole, carnosine, sulfanilamide and flufenamic acid. Our results with folic acid led us to obtain promising Ionic Liquids that unfortunately show glass transitions. From some of them it was possible to have good powder diffraction data, already indexed, and for some we could get a crystal structure such as the one depicted for Cu:adenine BioMOF, Cu:Flufenamic acid coordination compound and Mg:Muconic acid 1D chain. These are results from a previuos experiment at ESRF (CH4160) at BM25a and BM01a. We have evidence of the formation of several novel compounds with these systems, but their structural characterization has been precluded due do the existence of mixed phases and by the impossibility of growing good enough crystals.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>List of scans and samples tested</head><p>Table I -List of tested samples and respective data collection conditions Scan # SAMPLE Program ZAPLINE TIME /h 1-4 Tests ---------------ASA:CAF TTH -50.004 19.3 17326 400 2 6-7 Tests ---------------ASA:CAF TTH -47.7633 14.3 18619 2500 13 ASA:CAF TTH -47.7633 14.3 18619 2000 11 AZ:Mg TTH -47.764 14.3 15516 2500 11 11-38 Tests ---------------FG 3.12.A1 TTH -47.764 14.3 15516 1000 4 DAP5 (DAP:Zn) TTH -47.764 14.3 15516 2200 9 Tiago E TTH -47.78 -0.7 2354 500 0.3 Tiago B TTH -47.78 -0.7 2354 800 0.5 Tiago H TTH -47.78 -0.7 2354 500 0.5 Tiago BZ TTH -47.78 -0.7 2354 500 0.5 Inês_AF:oxalic TTH -47.764 14.3 15516 400 2 ASA:CAF TTH -47.764 14.3 15516 1600 6 ALOP11 TTH -47.764 14.3 15516 2500 11 ASA:VAN TTH -47.764 14.3 15516 400 2 ASA:VAN TTH -47.764 14.3 15516 1600 6 FG 3.12.1A TTH -47.764 14.3 15516 400 2 ASA11 TTH -46.764 9.3 14016 1000 4 ASA10 TTH -46.764 9.3 14016 1600 6 Test ---------------ASA17 TTH -46.764 9.3 14016 1000 4 FG 1.12.1 TTH -47.764 9.3 14266 1500 6 FG 1.12A1 TTH -47.764 9.3 14266 1500 6 FG 1.12B1 TTH -47.764 9.3 14266 1800 8</p><p>Samples Tiago E, B, H and BZ (scans 41-44)</p><p>These are extremely air-sensitive samples and thus we had no previous information about the diffraction of the samples.  Indexing and space group determination is already done for this sample.</p><p>Table II -Indexing and space group determination Method: N-Treor a= 12.82009 Å α= 90⁰ b= 23.58294 Å β= 95.342⁰ c= 5.91165 Å = 90⁰ Symmetry: Monoclinic Space group: P2 1 /n Figure 9 -Diffractogram of the sum of scans 5 and 46 (scans 8 and 9 were tests that were ignored for this sum)</p><p>Data collected for this sample is promising for structure solution. Indexing and space group determination is already done for this sample.</p><p>Table III -Indexing and space group determination Method: N-Treor a= 16.44686 Å α= 99.268⁰ b= 17.39341 Å β= 103.430⁰ c= 11.60782 Å = 105.029⁰ Symmetry: Triclinic Space group: P-1 Figure 10 -Data from the Debye-Scherrer detector, ESRF </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>· Zn</head><p>Data collected for this sample is promising for structure solution. Indexing and space group determination is already done for this sample.</p><p>Table IV -Indexing and space group determination Method: N-Treor a= 9.1102 Å α= 103.93⁰ b= 16.9127 Å β= 90.18⁰ c= 8.2006 Å = 99.27⁰ Symmetry: Triclinic Space group: P-1 Figure 16 -Diffractogram of the sum of detectors Data collected for this sample is promising for structure solution. Indexing and space group determination is already done for this sample.</p><p>Table V -Indexing and space group determination Method: N-Treor a= 9.1102 Å α= 103.93⁰ b= 16.9127 Å β= 90.18⁰ c= 8.2006 Å = 99.27⁰ Symmetry: Triclinic Space group: P-1</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>· Mg</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p>A reasonably large number of samples was analysed at BM25A from 28 th January to 2 nd February 2016.</p><p>Even though some of these samples do not have good enough data (low crystallinity and/or low resolution), quit a few of them seem very promising for crystal structure solution. Indexing and space group determinations is already accomplished for 4 samples and it is an on-going work for at least 5 more that we are confident that can retrieve structure solution.</p><p>This is an on-going work which we believe that will retrieve quite interesting results.</p><p>Finally we would like to acknowledge ESRF for considering our application and BM25A for conceding us beam time. To Dr. German Castro we thank all his support.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 -Figure 4 -</head><label>24</label><figDesc>Figure 2 -Data from the Debye-Scherrer detector, ESRF</figDesc><graphic coords="8,85.05,195.49,425.06,302.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 8 -</head><label>8</label><figDesc>Figure 8 -Diffractograms from all the detectors (except detector 0 due to lack of signal)normalized data</figDesc><graphic coords="14,134.90,70.85,325.34,227.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc>Scheme V -Expected content of the unit cell</figDesc><graphic coords="15,85.05,258.97,425.10,265.85" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><figDesc>Scheme VI -Expected content of the unit cell</figDesc><graphic coords="16,334.27,169.64,78.65,86.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><figDesc>Scheme XII -Expected content of the unit cell</figDesc><graphic coords="23,200.40,250.67,101.10,78.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="1,260.64,243.72,334.68,252.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="4,110.90,324.69,372.50,228.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="9,85.05,140.61,425.20,328.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="18,85.05,295.81,425.30,276.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="21,85.05,273.40,425.19,374.42" type="bitmap" /></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data collection conditions</head><p>All samples were analyzed with the Debye-Scherrer and the multi-crystal detectors, which includes 10 detectors. However only for the first sample analyzed all the detectors were correctly retrieving signal. Detector 0 is ignored in most samples. Case by case analysis was done to check which detectors' data could be used.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample Inês_AF:oxalic acid (Scan 45)</head><p>This sample was only collected for 2 hours. The resolution of the sample was not very good and therefore no longer data collection was carried out and no further studies for structure solution from these data will be carried out.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample FG_1_12_1 (scan 55)</head><p>Expected contents: Ibuprofeno + L-Prolina ( 1:1)</p><p>Scheme II -Expected content of the unit cell Data collected for this sample is similar to the data for the sample FG_1_12_1 and is also promising for structure solution. Indexing and space group determination is an on-going work.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample FG_3_12_A1 (scans 39 and 50)</head><p>Expected contents: Flurbiprofeno + DL-prolina (1:1)</p><p>Scheme IV -Expected content of the unit cell </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Table 1: Summary of collection details and 16S rRNA gene sequencing results for aphid samples.</title>
		<author>
			<orgName type="collaboration">Table of Contents ........................................................................................................................... i SpLine BM25A -details .................................................................................................................. Proposal summary......................................................................................................................... Scientific background .................................................................................................................... List of scans and samples tested ................................................................................................... Data collection conditions ................................................</orgName>
		</author>
		<idno type="DOI">10.7717/peerj.4725/table-1</idno>
		<imprint>
			<date>null</date>
			<publisher>PeerJ</publisher>
		</imprint>
	</monogr>
	<note>............................................................</note>
	<note type="raw_reference">Table of Contents ........................................................................................................................... i SpLine BM25A -details .................................................................................................................. Proposal summary......................................................................................................................... Scientific background .................................................................................................................... List of scans and samples tested ................................................................................................... Data collection conditions .............................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">E</forename><surname>Samples Tiago</surname></persName>
			<affiliation>
				<orgName type="collaboration">scans 41-44) .................................................................................</orgName>
			</affiliation>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bz</surname></persName>
			<affiliation>
				<orgName type="collaboration">scans 41-44) .................................................................................</orgName>
			</affiliation>
		</author>
		<imprint/>
	</monogr>
	<note type="raw_reference">Samples Tiago E, B, H and BZ (scans 41-44) ..................................................................................</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Oxalic Acid</title>
		<author>
			<orgName type="collaboration">Sample Inês_AF:oxalic acid (Scan 45)...........................................................................................</orgName>
		</author>
		<idno type="DOI">10.31003/uspnf_r2260_01_01</idno>
		<imprint>
			<date>null</date>
			<publisher>U.S. Pharmacopeial Convention</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample Inês_AF:oxalic acid (Scan 45)............................................................................................</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">SUPELCO, INC.</title>
		<author>
			<orgName type="collaboration">Sample FG_1_12A_1 (scan 56) .....................................................................................................</orgName>
		</author>
		<idno type="DOI">10.1021/ac00265a707</idno>
	</analytic>
	<monogr>
		<title level="j">Analytical Chemistry</title>
		<title level="j" type="abbrev">Anal. Chem.</title>
		<idno type="ISSN">0003-2700</idno>
		<idno type="ISSNe">1520-6882</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="12A" to="12A" />
			<date type="published" when="1984-01-01" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample FG_1_12A_1 (scan 56) ......................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample FG_1_12_1 (scan 55) .......................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample FG_1_12_1 (scan 55) ........................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Figure 12—source data 1. Source data for Figure 12B.</title>
		<author>
			<orgName type="collaboration">Sample FG_1_12B_1 (Scan 57)...................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.28118.025</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample FG_1_12B_1 (Scan 57)....................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Figure A1: Sample of primary data.</title>
		<author>
			<orgName type="collaboration">Sample FG_3_12_A1 (scans 39 and 50) .....................................................................................</orgName>
		</author>
		<idno type="DOI">10.7717/peerj-cs.646/fig-a1</idno>
		<imprint>
			<date>null</date>
			<publisher>PeerJ</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample FG_3_12_A1 (scans 39 and 50) ......................................................................................</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<author>
			<persName><forename type="first">Asa</forename><surname>Sample</surname></persName>
			<affiliation>
				<orgName type="collaboration">......................................................................................</orgName>
			</affiliation>
		</author>
		<title level="m">CAF (Scans 5, 8, 9 and 46)</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Sample ASA:CAF (Scans 5, 8, 9 and 46) .......................................................................................</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">SEE Question</title>
		<author>
			<orgName type="collaboration">Sample ASA:VAN (Scans 48 and 49) ...........................................................................................</orgName>
		</author>
		<idno type="DOI">10.1097/01.asm.0001076936.42683.96</idno>
	</analytic>
	<monogr>
		<title level="j">ASA Monitor</title>
		<title level="j" type="abbrev">ASA Monitor</title>
		<idno type="ISSN">0270-5877</idno>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="48" to="49" />
			<date type="published" when="2018-05" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample ASA:VAN (Scans 48 and 49) ............................................................................................</note>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample ASA10 (Scan 52) .............................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample ASA10 (Scan 52) ..............................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample ASA11 (Scan 51) .............................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample ASA11 (Scan 51) ..............................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample ASA17 (scan 54) .............................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample ASA17 (scan 54) ..............................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample Alopurinol 11 (Scan 47) .................................................................................................. Sample DAP5_Zn (Scan 40) ........................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample Alopurinol 11 (Scan 47) .................................................................................................. Sample DAP5_Zn (Scan 40) .........................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Table 1. Sample characteristics and scan parameters</title>
		<author>
			<orgName type="collaboration">Sample AZ:Mg (Scan 10) .............................................................................................................</orgName>
		</author>
		<idno type="DOI">10.7554/elife.46797.002</idno>
		<imprint>
			<date>null</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Sample AZ:Mg (Scan 10) ..............................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Conclusions générales | General Conclusions</title>
		<author>
			<orgName type="collaboration">Conclusions ................................................................................................................................</orgName>
		</author>
		<idno type="DOI">10.1163/1875-8096_pplcoll_ej.9789041101549.15_648.122</idno>
		<imprint>
			<date>null</date>
			<publisher>Walter de Gruyter GmbH</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Conclusions .................................................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Voltage References</title>
		<author>
			<orgName type="collaboration">References ..................................................................................................................................</orgName>
		</author>
		<idno type="DOI">10.1109/9780470547038.ch3</idno>
	</analytic>
	<monogr>
		<title level="m">Voltage References</title>
		<imprint>
			<publisher>IEEE</publisher>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note type="raw_reference">References ...................................................................................................................................</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Supplemental Material for Proceedings of the American Psychological Association for the Legislative Year 2014 : Minutes of the Annual Meeting of the Council of Representatives, February 21–23, 2014, Washington, DC, and August 6 and August 8, 2014, Washington, DC, and Minutes of the February, June, August, and December 2014 Meetings of the Board of Directors</title>
		<idno type="DOI">10.1037/a0039369.supp</idno>
	</analytic>
	<monogr>
		<title level="j">American Psychologist</title>
		<title level="j" type="abbrev">American Psychologist</title>
		<idno type="ISSN">0003-066X</idno>
		<idno type="ISSNe">1935-990X</idno>
		<imprint>
			<date type="published" when="2015">August 23-28, 2015</date>
			<publisher>American Psychological Association (APA)</publisher>
			<pubPlace>Rovinj, Croatia</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Results of our recent stay in December and February at the ESRF are going to be presented at the 8th Bologna&apos;s Convention on Crystal Forms -Crystals in Food &amp; Pharma in June, at the National Chemistry Meeting, in July in Coimbra, and at the 29th European Crystallographic Meeting, August 23-28, 2015 in Rovinj, Croatia</note>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Our trip into the mechanochemistry world: From polymorphs and co-crystals to metallodrugs and bio-inspired metal organic frameworks, making a detour into green synthesis of catalysts</title>
		<author>
			<persName><forename type="first">S</forename><surname>André</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Quaresma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S B</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Gomes</surname></persName>
		</author>
		<author>
			<persName><surname>Duarte</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014-06">June 2014</date>
			<pubPlace>Waterville Valley, USA</pubPlace>
		</imprint>
		<respStmt>
			<orgName>Crystal Engineering -Gordon Research Seminar</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">Results from previous stays : a)V.André, S. Quaresma, M. Martins, C. S. B. Gomes, M. T. Duarte, Our trip into the mechanochemistry world: From polymorphs and co-crystals to metallodrugs and bio-inspired metal organic frameworks, making a detour into green synthesis of catalysts, Crystal Engineering -Gordon Research Seminar, Waterville Valley, USA, June 2014;</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Position Based Rigid Body Simulation: A comparison of physics simulators for games</title>
		<author>
			<persName><forename type="first">Miguel</forename><surname>Seabra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francisco</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Daniel</forename><forename type="middle">Simões</forename><surname>Lopes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">João</forename><forename type="middle">Madeiras</forename><surname>Pereira</surname></persName>
		</author>
		<idno type="DOI">10.24132/csrn.3301.59</idno>
	</analytic>
	<monogr>
		<title level="m">Computer Science Research Notes</title>
		<meeting><address><addrLine>IST, Lisbon, Portugal</addrLine></address></meeting>
		<imprint>
			<publisher>University of West Bohemia, Czech Republic</publisher>
			<date type="published" when="2023-07" />
			<biblScope unit="page" from="351" to="360" />
		</imprint>
	</monogr>
	<note type="raw_reference">V. André, XRD and ESRF-applications in pharmaceutical crystal forms, Methods of Structure Elucidation -2014, IST, Lisbon, Portugal;</note>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<author>
			<persName><forename type="first">V</forename><surname>André</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Duarte</surname></persName>
		</author>
		<title level="m">Bio-MOFs as potential drug delivery materials: a new approach to traditional MOFs, 1st Cluster Workshop in Materials and Nanotechnology</title>
		<meeting><address><addrLine>IST, Lisbon, Portugal</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2013-12-06">6 December 2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">V. André, M. T. Duarte, Bio-MOFs as potential drug delivery materials: a new approach to traditional MOFs, 1st Cluster Workshop in Materials and Nanotechnology, IST, Lisbon, Portugal, 6 December 2013.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title/>
		<author>
			<persName><surname>Rocca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acc. Chem. Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">957</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rocca et al. Acc. Chem. Res,, 44 (2011) 957;</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Metal–biomolecule frameworks (MBioFs)</title>
		<author>
			<persName><forename type="first">Inhar</forename><surname>Imaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marta</forename><surname>Rubio-Martínez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jihyun</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabel</forename><surname>Solé-Font</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nathaniel</forename><forename type="middle">L</forename><surname>Rosi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Daniel</forename><surname>Maspoch</surname></persName>
		</author>
		<idno type="DOI">10.1039/c1cc11202c</idno>
	</analytic>
	<monogr>
		<title level="j">Chemical Communications</title>
		<title level="j" type="abbrev">Chem. Commun.</title>
		<idno type="ISSN">1359-7345</idno>
		<idno type="ISSNe">1364-548X</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page">7287</biblScope>
			<date type="published" when="2011">2011</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Imaz et al. ChemComm, 47 (2011) 7287</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Cation-Triggered Drug Release from a Porous Zinc−Adeninate Metal−Organic Framework</title>
		<author>
			<persName><forename type="first">Jihyun</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Steven</forename><forename type="middle">J</forename><surname>Geib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nathaniel</forename><forename type="middle">L</forename><surname>Rosi</surname></persName>
		</author>
		<idno type="DOI">10.1021/ja902972w</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Chemical Society</title>
		<title level="j" type="abbrev">J. Am. Chem. Soc.</title>
		<idno type="ISSN">0002-7863</idno>
		<idno type="ISSNe">1520-5126</idno>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="8376" to="8377" />
			<date type="published" when="2009-06-02">2009</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">An, J. Y., Geib, S. J. &amp; Rosi, N. L. (2009). Journal of the American Chemical Society 131, 8376-8377;</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Flexible Porous Metal-Organic Frameworks for a Controlled Drug Delivery</title>
		<author>
			<persName><forename type="first">Patricia</forename><surname>Horcajada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Serre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Guillaume</forename><surname>Maurin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Naseem</forename><forename type="middle">A</forename><surname>Ramsahye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francisco</forename><surname>Balas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">María</forename><surname>Vallet-Regí</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Muriel</forename><surname>Sebban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francis</forename><surname>Taulelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gérard</forename><surname>Férey</surname></persName>
		</author>
		<idno type="DOI">10.1021/ja710973k</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Chemical Society</title>
		<title level="j" type="abbrev">J. Am. Chem. Soc.</title>
		<idno type="ISSN">0002-7863</idno>
		<idno type="ISSNe">1520-5126</idno>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="6774" to="6780" />
			<date type="published" when="2008-05-01">2008</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Horcajada, P., Serre, C., Maurin, G., Ramsahye, N. A., Balas, F., Vallet-Regi, M., Sebban, M., Taulelle, F. &amp; Ferey, G. (2008). Journal of the American Chemical Society 130, 6774-6780.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Metal–Organic Frameworks as Efficient Materials for Drug Delivery</title>
		<author>
			<persName><forename type="first">Patricia</forename><surname>Horcajada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Serre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">María</forename><surname>Vallet‐regí</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Muriel</forename><surname>Sebban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francis</forename><surname>Taulelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gérard</forename><surname>Férey</surname></persName>
		</author>
		<idno type="DOI">10.1002/anie.200601878</idno>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<title level="j" type="abbrev">Angew Chem Int Ed</title>
		<idno type="ISSN">1433-7851</idno>
		<idno type="ISSNe">1521-3773</idno>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">36</biblScope>
			<biblScope unit="page" from="5974" to="5978" />
			<date type="published" when="2006-09-05">2006</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Horcajada, P., Serre, C., Vallet-Regi, M., Sebban, M., Taulelle, F. &amp; Ferey, G. (2006). Angewandte, Chemie-International Edition 45, 5974-5978.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Biodegradable therapeutic MOFs for the delivery of bioactive molecules</title>
		<author>
			<persName><forename type="first">Stuart</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Daniela</forename><surname>Heurtaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tarek</forename><surname>Baati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Patricia</forename><surname>Horcajada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jean-Marc</forename><surname>Grenèche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Serre</surname></persName>
		</author>
		<idno type="DOI">10.1039/c001181a</idno>
	</analytic>
	<monogr>
		<title level="j">Chemical Communications</title>
		<title level="j" type="abbrev">Chem. Commun.</title>
		<idno type="ISSN">1359-7345</idno>
		<idno type="ISSNe">1364-548X</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page">4526</biblScope>
			<date type="published" when="2010">2010</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Miller, S. R., Heurtaux, D., Baati, T., Horcajada, P., Greneche, J. M. &amp; Serre, C. (2010). Chemical, Communications 46, 4526-4528.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Anionic zinc-trimesic acid MOFs with unusual topologies: Reversible hydration studies</title>
		<author>
			<persName><forename type="first">Kate</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Susan</forename><forename type="middle">A</forename><surname>Bourne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lars</forename><surname>Öhrström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clive</forename><forename type="middle">L</forename><surname>Oliver</surname></persName>
		</author>
		<idno type="DOI">10.1039/b922690g</idno>
	</analytic>
	<monogr>
		<title level="j">Dalton Transactions</title>
		<title level="j" type="abbrev">Dalton Trans.</title>
		<idno type="ISSN">1477-9226</idno>
		<idno type="ISSNe">1477-9234</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">2869</biblScope>
			<date type="published" when="2010">2010</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Davies, K., Bourne, S. A., Ohrstrom, L. &amp; Oliver, C. L. (2010). Dalton Transactions 39, 2869- 2874.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">ChemInform Abstract: BioMOFs: Metal—Organic Frameworks for Biological and Medical Applications</title>
		<author>
			<persName><forename type="first">Alistair</forename><forename type="middle">C</forename><surname>Mckinlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Russell</forename><forename type="middle">E</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Patricia</forename><surname>Horcajada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gerard</forename><surname>Ferey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ruxandra</forename><surname>Gref</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Patrick</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Serre</surname></persName>
		</author>
		<idno type="DOI">10.1002/chin.201103263</idno>
	</analytic>
	<monogr>
		<title level="j">ChemInform</title>
		<title level="j" type="abbrev">ChemInform</title>
		<idno type="ISSN">0931-7597</idno>
		<idno type="ISSNe">1522-2667</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2010-12-23" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">McKinlay, A. C., Morris, R. E., Horcajada, P., Ferey, G., Gref, R., Couvreur, P. &amp; Serre, C.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications</title>
		<author>
			<persName><forename type="first">Alistair</forename><forename type="middle">C</forename><surname>Mckinlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Russell</forename><forename type="middle">E</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Patricia</forename><surname>Horcajada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gérard</forename><surname>Férey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ruxandra</forename><surname>Gref</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Patrick</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Serre</surname></persName>
		</author>
		<idno type="DOI">10.1002/anie.201000048</idno>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<title level="j" type="abbrev">Angew Chem Int Ed</title>
		<idno type="ISSN">1433-7851</idno>
		<idno type="ISSNe">1521-3773</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">36</biblScope>
			<biblScope unit="page" from="6260" to="6266" />
			<date type="published" when="2010-07-22" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Angewandte Chemie-International Edition 49, 6260-6266.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Zeolite-like metal–organic frameworks (ZMOFs): design, synthesis, and properties</title>
		<author>
			<persName><forename type="first">Mohamed</forename><surname>Eddaoudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dorina</forename><forename type="middle">F</forename><surname>Sava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jarrod</forename><forename type="middle">F</forename><surname>Eubank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Karim</forename><surname>Adil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vincent</forename><surname>Guillerm</surname></persName>
		</author>
		<idno type="DOI">10.1039/c4cs00230j</idno>
	</analytic>
	<monogr>
		<title level="j">Chemical Society Reviews</title>
		<title level="j" type="abbrev">Chem. Soc. Rev.</title>
		<idno type="ISSN">0306-0012</idno>
		<idno type="ISSNe">1460-4744</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="228" to="249" />
			<date type="published" when="2015">2015</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Eddaoudi, D. F. Sava, J. F. Eubank, K. Adil and V. Guillerm, Chemical Society reviews, 2015, 44, 228-249;</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Zeolitic imidazolate framework materials: recent progress in synthesis and applications</title>
		<author>
			<persName><forename type="first">Binling</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zhuxian</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yanqiu</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yongde</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1039/c4ta02984d</idno>
	</analytic>
	<monogr>
		<title level="j">J. Mater. Chem. A</title>
		<title level="j" type="abbrev">J. Mater. Chem. A</title>
		<idno type="ISSN">2050-7488</idno>
		<idno type="ISSNe">2050-7496</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">40</biblScope>
			<biblScope unit="page" from="16811" to="16831" />
			<date type="published" when="2014">2014</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">B. Chen, Z. Yang, Y. Zhu and Y. Xia, Journal of Materials Chemistry A, 2014, 2, 16811-16831;</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">CAF@ZIF-8: One-Step Encapsulation of Caffeine in MOF</title>
		<author>
			<persName><forename type="first">Nuria</forename><surname>Liédana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alejandro</forename><surname>Galve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">César</forename><surname>Rubio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Carlos</forename><surname>Téllez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Joaquín</forename><surname>Coronas</surname></persName>
		</author>
		<idno type="DOI">10.1021/am301365h</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Applied Materials &amp; Interfaces</title>
		<title level="j" type="abbrev">ACS Appl. Mater. Interfaces</title>
		<idno type="ISSN">1944-8244</idno>
		<idno type="ISSNe">1944-8252</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="5016" to="5021" />
			<date type="published" when="2012-08-20">2012</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">N. Liedana, A. Galve, C. Rubio, C. Tellez and J. Coronas, Acs Applied Materials &amp; Interfaces, 2012, 4, 5016-5021.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
